Inventor · disambiguated record
Jens Hoffmann
Also filed as: HOFFMANN JENS
16 granted patents·21 pending applications·56 citations·filing 1999–2020
90Inventor score
Top patents by PatentIndex Score
37 records- 0181US7125893B16-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparationsSCHERING AG·Filed 2000·Granted Oct 24, 2006·11 cites·24 claims
- 0279US6956031B211β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 18, 2005·12 cites·17 claims
- 0377US6861432B2Piperazine derivatives that destabilize androgen receptorsSCHERING AG·Filed 2002·Granted Mar 1, 2005·11 cites·20 claims
- 0473US6790842B111β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTSSCHERING AG·Filed 2000·Granted Sep 14, 2004·7 cites·15 claims
- 0568US7018994B217α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONSSCHERING AG·Filed 2002·Granted Mar 28, 2006·3 cites·28 claims
- 0665US7645891B26-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparationsBAYER SCHERING PHARMA AG·Filed 2004·Granted Jan 12, 2010·1 cites·5 claims
- 0762US6747046B2Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agentsSCHERING AG·Filed 2002·Granted Jun 8, 2004·1 cites·9 claims
- 0861US7605136B2Effector conjugates, methods for their preparation and their pharmaceutical useBAYER SCHERING PHARMA AG·Filed 2003·Granted Oct 20, 2009·0 cites·21 claims
- 0959US2021040528A1Feed mixing device and its useHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1058US2007238714A1Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesFUHRMANN ULRIKE·Filed 2007·Application pending·0 cites
- 1157US7700621B26-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparationsBAYER SCHERING PHARMA AG·Filed 2005·Granted Apr 20, 2010·0 cites·28 claims
- 1255US2005014736A1Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesFiled 2004·Application pending·0 cites
- 1354US10837042B2Feed mixing device and its useHOFFMANN LA ROCHE·Filed 2017·Granted Nov 17, 2020·0 cites·8 claims
- 1454US7378406B2Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseasesSCHERING AG·Filed 2001·Granted May 27, 2008·0 cites·15 claims
- 1553US2004242551A1Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesSCHERING AG·Filed 2003·Application pending·0 cites
- 1652US6767903B1New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseasesSCHERING AG·Filed 1999·Granted Jul 27, 2004·10 cites·14 claims
- 1751US7538100B217α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparationsBAYER SCHERING PHARMA AG·Filed 2005·Granted May 26, 2009·0 cites·27 claims
- 1851US2010168179A16-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparationsKLAR ULRICH·Filed 2010·Application pending·0 cites
- 1951US2004186156A1Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agentsFiled 2004·Application pending·0 cites
- 2051US2009163450A1Combinations comprising a prostaglandin and uses thereofHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 2150US2006069136A1Use of Epothilones in the treatment of bone metastasisKLAR ULRICH·Filed 2005·Application pending·0 cites
- 2249US2003013694A1Use and compositions of antiprogestins for treatment of prostate diseasesFiled 2002·Application pending·0 cites
- 2349US2014051121A1Feed mixing device and its useHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2448US8026229B2Antitumor-active 2-alkoxyestradiol sulfamatesSTERIX LTD·Filed 2002·Granted Sep 27, 2011·0 cites·21 claims
- 2546US7119082B211β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 10, 2006·0 cites·20 claims
- 2646US2009076098A1Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilonesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 2746US2008268041A1Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 2846US2009029954A1Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogenHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 2946US2008261929A1Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 3046US2008261933A1Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseasesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 3145US8524722B2Substituted tricyclic compounds and methods of use thereofSCHIROK HARTMUT·Filed 2008·Granted Sep 3, 2013·0 cites·20 claims
- 3245US2006276413A1New effector conjugates, methods for their preparation and their pharmaceutical useBOSSLET KLAUS·Filed 2006·Application pending·0 cites
- 3343US2004019088A1Use of Epothilones in the treatment of brain diseases associated with proliferative processesSCHERING AG·Filed 2003·Application pending·0 cites
- 3440US2004072811A1Use of antiprogestins for the induction of apoptosis in a cellFiled 2001·Application pending·0 cites
- 3539US2004058969A1Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical useFiled 2001·Application pending·0 cites
- 3638US2003139460A19-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparationsFiled 2001·Application pending·0 cites
- 3738US2006257322A1Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilonesLAWACZECK RUEDIGER·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Hoffmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →